William Hoffman - 04 Jan 2022 Form 4/A - Amendment Insider Report for Inari Medical, Inc.

Role: President and CEO, Director
Signature: /s/ Angela Ahmad, attorney-in-fact for William Hoffman
Issuer symbol: N/A
Transactions as of: 04 Jan 2022
Net transactions value: +$12,091
Form type: 4/A - Amendment
Filing time: 09 Feb 2022, 18:52:26 UTC
Date Of Original Report: 06 Jan 2022
Previous filing: 04 Jan 2022
Next filing: 09 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NARI	Common Stock	Options Exercise	$12,091	+28,249	+5.5%	$0.4280^*	538,618	04 Jan 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NARI	Stock Options (Right to buy)	Options Exercise	$0	-28,249	-11%	$0.000000	230,467	04 Jan 2022	Common Stock	28,249	$0.4280	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2021.
F2	Option vested with respect to 25% of the underline shares on May 3, 2019 and vest with respect to the remaining shares in 36 equal monthly installments thereafter.

Remarks:

This amended Form 4 is being filed solely to show that the shares acquired were sold as reported in previously filed Form 4s.